예지 · Yeji

Catch the moves big firms see first.

Yeji tracks every SEC filing, FDA decision, Form 4 insider trade, and clinical trial readout across the SMID-cap biotech universe — and surfaces the signals that matter before the calendar competitors notice.

Daily digest. Quiet days get skipped — no inbox spam. See a sample issue →

Live signal · 81d ago

$CORTCORCEPT THERAPEUTICS INC

BAKER G LEONARD JR (Director) bought $2.50M in open-market shares — discretionary, not under a pre-scheduled 10b5-1 plan.

This is exactly the pattern Yeji catches.

Data fromSEC EDGAR· filings + Form 4FDA· approvals + AdComsClinicalTrials.gov· trial readoutsopenFDA· application status

Next 60 days

Highest-confidence catalysts surfacing soon.

See all

PDUFAJul 11, 2026· in 36d

$CORTCORCEPT THERAPEUTICS INC

relacorilant · hypertension secondary to hypercortisolism

“The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of July 11, 2026 for relacorilant as a treatment for patients with platinum-resistant ovarian cancer.”

Jul 11, 2026

in 36d

Want the signals in your inbox?

One daily digest. Insider clusters, upcoming PDUFAs, recent FDA decisions. Quiet days skipped — your inbox stays signal-only.